Clinical Trials in Pittsburgh

Showing 1741-1760 of 10,050 trials

Minima Stent System Post- Approval Study (PAS)

NCT06828770

This Post-Approval Study is a single arm, prospective, multi-center, open-label study of patients treated with the Renata Minima Stent System in the United States. The objective of the study is to continue the assessment of device performance and capture outcome data on use of the device in real-world use.

Pulmonary Artery StenosisAortic Coarctation

Renata Medical100 participantsStarted May 2025

Los Angeles, California, United States • Aurora, Colorado, United States • Miami, Florida, United States +12 more locations

TERMINATEDPhase 1< 1 mile

Intrahepatic Delivery of SD-101 by Pressure-Enabled Regional Immuno-oncology (PERIO), With Checkpoint Blockade in Adults With Metastatic Uveal Melanoma

NCT04935229

This study is an open-label, phase 1/1b study of the pressure-enabled hepatic artery infusion of SD-101, a TLR 9 agonist, alone or in combination with intravenous checkpoint blockade in adults with metastatic uveal melanoma.

Metastatic Uveal Melanoma in the Liver

TriSalus Life Sciences, Inc.67 participantsStarted Aug 2021

Los Angeles, California, United States • Stanford, California, United States • Denver, Colorado, United States +7 more locations

Minima Stent System Post- Approval Study (PAS)

Intrahepatic Delivery of SD-101 by Pressure-Enabled Regional Immuno-oncology (PERIO), With Checkpoint Blockade in Adults With Metastatic Uveal Melanoma

Find Trials by Condition in Pittsburgh

Feasibility of Bridge for Post-Operative Pain Management in Hip Arthroplasty

Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata

A Study to Investigate Vamikibart (RO7200220) in Diabetic Macular Edema

EValuating trEatment RESponses of Dupilumab Versus Omalizumab in Type 2 Patients

Tissue Reinforcement for Breast Reconstruction (TRBR) Pivotal Clinical Study (REDEFINE)

Vincristine Sulfate Liposome Injection (Marqibo®) in Combination With UK ALL R3 Induction Chemotherapy

A Study of Olezarsen Administered Subcutaneously to Participants With Severe Hypertriglyceridemia

Safety and Proof-of-Concept (POC) Study With AMT-130 in Adults With Early Manifest Huntington's Disease

CaRi-Heart Assessment of Risk and Evaluation of Inflammation in Coronary CT Angiography (CARE-CCTA)

Study of VIR-2218, VIR-3434, and/or PEG-IFNα in Subjects With Chronic Hepatitis B Virus Infection

To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL

A Phase 3 Study of Zalunfiban in Subjects With ST-elevation MI

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder

Study of Subcutaneous (SC) Belimumab in Pediatric Participants With Systemic Lupus Erythematosus (SLE)

Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants With SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)

Azacitidine Combined With Pembrolizumab and Epacadostat in Subjects With Advanced Solid Tumors (ECHO-206)

Real-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States:

Non-Operative Management and Early Response Assessment in Rectal Cancer